Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
Journal website http://www.jofem.org |
Case Report
Volume 7, Number 3, June 2017, pages 94-97
Effect of Tofogliflozin on Cardiac Function: Potential Link Between Ketone Bodies and the Heart
Table
Patient A | Patient B | Patient C | |
---|---|---|---|
These parameters are measured at baseline and at 3 months. | |||
Age (years) | 65 | 68 | 60 |
Body height (cm) | 162 | 168 | 165 |
CTR (%) | 58 | 50 | 55 |
Body weight (kg) | |||
Baseline | 64.2 | 89 | 76.85 |
3 months | 63.05 | 90.2 | 77.45 |
HbA1c (%) | |||
Baseline | 7.3 | 8.9 | 9.8 |
3 months | 7.6 | 11.4 | 9 |
EF | |||
Baseline | 47.8 | 69.3 | 47.7 |
3 months | 61.1 | 66.5 | 47.7 |
%FS | |||
Baseline | 24.8 | 38.9 | 24.4 |
3 months | 33.1 | 36.7 | 24.4 |
BNP (pg/mL) | |||
Baseline | 71.7 | 7.2 | 55.7 |
3 months | 17.1 | 4.7 | 53.7 |
Acetoacetate (µmol/L) | |||
Baseline | 19 | 63 | 30 |
3 months | 29 | 36 | 30 |
Beta-hydroxybutyrate (µmol/L) | |||
Baseline | 46 | 142 | 75 |
3 months | 53 | 83 | 88 |
Hb (g/dL) | |||
Baseline | 12.9 | 16.5 | 14.6 |
3 months | 11.3 | 15.5 | 14.5 |